Genetic and peripheral biomarkers of comorbid posttraumatic stress disorder and traumatic brain injury: a systematic review
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 27, 2025
Background
Posttraumatic
stress
disorder
(PTSD)
commonly
cooccurs
with
traumatic
brain
injury
(TBI)
in
military
populations
and
is
a
significant
predictor
of
poor
long-term
outcomes;
however,
it
unclear
to
what
extent
specific
biological
variables
are
associated
comorbidity.
This
PROSPERO-registered
systematic
review
evaluates
the
current
body
literature
on
genetic
peripheral
biomarkers
comorbid
TBI
PTSD.
Methods
Searches
were
conducted
four
databases
(PubMed,
PsycInfo,
PTSDPubs,
Scopus).
We
included
published
studies
examining
differences
among
civilian,
military,
veteran
participants
both
PTSD
compared
those
alone
as
well
as,
some
cases,
healthy
controls.
Data
extracted
from
evidence
quality
was
assessed.
Results
Our
final
analysis
16
studies,
majority
which
based
data
active
duty
participants.
The
results
suggest
that
multiple
gene
variants
likely
contribute
cumulative
risk
TBI.
An
elevated
circulating
level
pro-inflammatory
cytokine
IL-6
most
consistently
replicated
blood-based
indicator
illness,
mTBI
alone.
Conclusion
Several
protein
markers
cellular
inflammation
appear
be
promising
indicators
chronic
pathology
Additional
research
needed
determine
how
such
factors
indicate,
predict,
comorbidity
they
represent
viable
targets
for
development
novel
diagnostic
tools
therapeutic
interventions.
Language: Английский
Feasibility of transcription factor EB as a serological metric of poor prognosis following moderate–severe traumatic brain injury: A prospective cohort study
Li Zhang,
No information about this author
Haiying Ma,
No information about this author
Xiaobing Zhang
No information about this author
et al.
Medicine,
Journal Year:
2025,
Volume and Issue:
104(18), P. e42271 - e42271
Published: May 2, 2025
Transcription
factor
EB
(TFEB)
is
an
endogenous
protective
factor.
Here,
we
sought
to
discern
the
possibility
of
serum
TFEB
as
a
prognostic
biomarker
moderate–severe
traumatic
brain
injury
(msTBI).
Serum
levels
141
patients
with
msTBI
and
70
controls
were
quantified
in
this
prospective
cohort
study.
Rotterdam
computed
tomography
(CT)
classification
Glasgow
coma
scale
(GCS)
considered
severity
metrics.
outcome
(GOS)
scores
1
3
at
6
months
after
trauma
meant
poor
prognosis.
The
results
analyzed
using
multivariate
analysis.
Patients
versus
had
notable
reduction
levels.
independent
correlation
CT
GCS
independently
relevant
continuous
GOS
ordinal
scores.
linear
relation
risk
prognosis
under
restricted
cubic
spline
predictive
Using
receiver
operating
characteristic
curve
analysis,
displayed
analogous
ability
constructed
model
by
merging
predictors,
that
TFEB,
scores,
was
pictorially
exhibited
via
nomogram,
demonstrated
perform
well
adopting
several
statistical
approaches.
An
obvious
decline
subsequent
are
firmly
related
neurological
outcomes
patients,
reinforcing
clinical
meaningfulness
biochemical
indicator
msTBI.
Language: Английский
A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative
The Lancet Neurology,
Journal Year:
2025,
Volume and Issue:
24(6), P. 512 - 523
Published: May 20, 2025
Language: Английский
Letter to the editor for: “A systematic review and meta-analysis of major blood protein biomarkers that predict unfavorable outcomes in severe traumatic brain injury”
Marios Lampros,
No information about this author
George Α. Alexiou,
No information about this author
Lamprini Vlachodimitropoulou
No information about this author
et al.
Clinical Neurology and Neurosurgery,
Journal Year:
2024,
Volume and Issue:
243, P. 108366 - 108366
Published: June 5, 2024
Language: Английский
Unveiling the predictive power of biomarkers in traumatic brain injury: A narrative review focused on clinical outcomes
Shuang Liang,
No information about this author
Zihui Hu
No information about this author
Biomedical Papers,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 17, 2024
Traumatic
brain
injury
(TBI)
has
long-term
consequences,
including
neurodegenerative
disease
risk.
Current
diagnostic
tools
are
limited
in
detecting
subtle
damage.
This
review
explores
emerging
biomarkers
for
TBI,
those
related
to
neuronal
injury,
inflammation,
EVs,
and
ncRNAs,
evaluating
their
potential
predict
clinical
outcomes
like
mortality,
recovery,
cognitive
impairment.
It
addresses
challenges
opportunities
implementing
practice,
aiming
improve
TBI
diagnosis,
prognosis,
treatment.
Language: Английский
Neurological Biomarker Profiles in Royal Canadian Air Force (RCAF) Pilots and Aircrew
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1296 - 1296
Published: Dec. 23, 2024
Background/Objectives:
Military
aviators
can
be
exposed
to
extreme
physiological
stressors,
including
decompression
stress,
G-forces,
as
well
intermittent
hypoxia
and/or
hyperoxia,
which
may
contribute
neurobiological
dysfunction/damage.
This
study
aimed
investigate
the
levels
of
neurological
biomarkers
in
military
assess
potential
risk
long-term
brain
injury
and
neurodegeneration.
Methods:
cross-sectional
involved
48
Canadian
Armed
Forces
(CAF)
non-aviator
CAF
controls.
Plasma
samples
were
analyzed
for
glial
activation
(GFAP),
axonal
damage
(NF-L,
pNF-H),
oxidative
stress
(PRDX-6),
neurodegeneration
(T-tau),
along
with
S100b,
NSE,
UCHL-1.
The
biomarker
concentrations
quantified
using
multiplexed
immunoassays.
Results:
exhibited
significantly
elevated
GFAP,
NF-L,
PRDX-6,
T-tau
compared
controls
(p
<
0.001),
indicating
increased
activation,
injury,
stress.
Trends
toward
higher
UCHL-1
observed
but
not
statistically
significant.
suggest
cumulative
damage,
raising
concerns
about
impairments.
Conclusions:
are
at
early
These
findings
emphasize
importance
proactive
monitoring
further
research
understand
impacts
high-altitude
flight
on
health
develop
strategies
mitigating
cognitive
decline
neurodegenerative
risks
this
population.
Language: Английский